120 related articles for article (PubMed ID: 38401631)
21. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium.
Luo D; Kim JH; Park C; Oh E; Park JB; Cui JH; Cao QR; Lee BJ
Int J Pharm; 2017 May; 523(1):343-356. PubMed ID: 28330645
[TBL] [Abstract][Full Text] [Related]
22. Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR.
Sahoo J; Murthy PN; Biswal S; Manik
AAPS PharmSciTech; 2009; 10(1):27-33. PubMed ID: 19145487
[TBL] [Abstract][Full Text] [Related]
23. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
24. Mucoadhesive platforms for targeted delivery to the colon.
Varum FJ; Veiga F; Sousa JS; Basit AW
Int J Pharm; 2011 Nov; 420(1):11-9. PubMed ID: 21856393
[TBL] [Abstract][Full Text] [Related]
25. Combined site-specific release retardant mini-matrix tablets (C-SSRRMT) for extended oral delivery of dexketoprofen trometamol:
Sweed NM; Basalious EB; Nour SA
Drug Dev Ind Pharm; 2019 Nov; 45(11):1777-1787. PubMed ID: 31418598
[TBL] [Abstract][Full Text] [Related]
26. Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD).
Kumar J; Newton A
Antiinflamm Antiallergy Agents Med Chem; 2016; 15(2):101-117. PubMed ID: 27449742
[TBL] [Abstract][Full Text] [Related]
27. Characterization of norfloxacine release from tablet coated with a new pH-sensitive polymer, P-4135F.
Hu Z; Shimokawa T; Ohno T; Kimura G; Mawatari SS; Kamitsuna M; Yoshikawa Y; Masuda S; Takada K
J Drug Target; 1999; 7(3):223-32. PubMed ID: 10680978
[TBL] [Abstract][Full Text] [Related]
28. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
Hosny EA; el-Mahrouk GM; Gouda MW
Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
[TBL] [Abstract][Full Text] [Related]
29. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.
Riekes MK; Dereymaker A; Berben P; Augustijns P; Stulzer HK; Van den Mooter G
Int J Pharm; 2017 Mar; 520(1-2):49-58. PubMed ID: 28153650
[TBL] [Abstract][Full Text] [Related]
30. Chronotherapeutic drug delivery of Tamarind gum, Chitosan and Okra gum controlled release colon targeted directly compressed Propranolol HCl matrix tablets and in-vitro evaluation.
Newton AM; Indana VL; Kumar J
Int J Biol Macromol; 2015 Aug; 79():290-9. PubMed ID: 25936283
[TBL] [Abstract][Full Text] [Related]
31. Site Targeted Press Coated Delivery of Methylprednisolone Using Eudragit RS 100 and Chitosan for Treatment of Colitis.
Jagdale S; Chandekar A
Recent Pat Antiinfect Drug Discov; 2016; 11(1):32-43. PubMed ID: 26377799
[TBL] [Abstract][Full Text] [Related]
32. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations.
Khan MZ; Stedul HP; Kurjaković N
Drug Dev Ind Pharm; 2000 May; 26(5):549-54. PubMed ID: 10789067
[TBL] [Abstract][Full Text] [Related]
33. Colon-targeted delivery of solubilized bisacodyl by doubly enteric-coated multiple-unit tablet.
Park HJ; Jung HJ; Ho MJ; Lee DR; Cho HR; Choi YS; Jun J; Son M; Kang MJ
Eur J Pharm Sci; 2017 May; 102():172-179. PubMed ID: 28279763
[TBL] [Abstract][Full Text] [Related]
34. Binders for colon specific drug delivery: an in vitro evaluation.
Sinha VR; Kumria R
Int J Pharm; 2002 Dec; 249(1-2):23-31. PubMed ID: 12433431
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo evaluation of tegaserod maleate pH-dependent tablets.
Zhang SQ; Thumma S; Chen GH; Deng WB; Repka MA; Li SM
Eur J Pharm Biopharm; 2008 May; 69(1):247-54. PubMed ID: 18037278
[TBL] [Abstract][Full Text] [Related]
36. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation.
Sareen R; Jain N; Rajkumari A; Dhar KL
Drug Deliv; 2016; 23(1):55-62. PubMed ID: 24758141
[TBL] [Abstract][Full Text] [Related]
37. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
Bendas ER; Christensen JM; Ayres JW
Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
[TBL] [Abstract][Full Text] [Related]
38. Sustained release enteric coated tablets of pantoprazole: formulation, in vitro and in vivo evaluation.
Wilson B; Babubhai PP; Sajeev MS; Jenita JL; Priyadarshini SR
Acta Pharm; 2013 Mar; 63(1):131-40. PubMed ID: 23482318
[TBL] [Abstract][Full Text] [Related]
39. Pulsatile systems for colon targeting of budesonide: in vitro and in vivo evaluation.
Yehia SA; Elshafeey AH; Elsayed I
Drug Deliv; 2011 Nov; 18(8):620-30. PubMed ID: 22111975
[TBL] [Abstract][Full Text] [Related]
40. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
